Cancer Clinical Trial
Official title:
Improving Palliative Care for Patients With Cancer
RATIONALE: Palliative care may help patients with advanced cancer live more comfortably.
PURPOSE: This randomized clinical trial is studying an early intervention palliative care
program to see how well it works compared to a standard care program in improving
end-of-life care in patients with advanced lung , gastrointestinal, genitourinary, or breast
cancer.
OBJECTIVES:
- Determine the efficacy of an early intervention palliative care program comprising a
phone-based nurse educator and shared medical appointments in improving end-of-life
care of patients with advanced lung, gastrointestinal, genitourinary, or breast cancer.
- Compare symptom management, quality of life, and the match between preference of care
and the care received in patients treated with an early intervention palliative care
program vs a standard care program.
- Compare health care utilization by patients treated with these interventions.
OUTLINE: This is a randomized, multicenter study. Patients are stratified according to
cancer diagnosis (lung vs breast vs gastrointestinal vs genitourinary) and participating
center. Patients are randomized to 1 of 2 intervention arms.
- Arm I (early-intervention palliative care program): Patients complete the Medical Care
Questionnaire and receive a computer-generated prescription letter that outlines the
problems they have identified; the patient's physician also receives a copy of the
letter. Patients receive a series of phone calls weekly for 4 weeks and then at least
monthly from a nurse educator. The phone calls address 3 major areas: coordination of
palliative care options in the cancer center and the patient's community, including
referrals for psychological or spiritual counseling, social work consultation,
financial guidance, home health, palliative care or hospice services, and bereavement
counseling for the family; problem-solving therapy, focusing on the identification of
problems, definition of achievable goals, a plan for reaching those goals, and
evaluation of success; and tailored psycho-educational modules from "Charting Your
Course", covering end-of-life topics such as symptom management, advanced care
planning, communication with the health care team and family members, spirituality, and
nutrition. Patients also receive information regarding the purpose and time/location of
symptom management, shared medical appointments (SMAs), which they can attend in person
or call in to participate via speaker phone. SMAs are 1.5-hour monthly sessions
conducted by a physician and a nurse practitioner that can accommodate 10-12 patients
and their caregivers. The sessions include a welcome/social period, a question and
answer/peer discussion, an interactive educational session, and an opportunity for
one-on-one nurse practitioner appointments with a focus on a brief review of the
patients' medical treatment plans.
- Arm II (standard palliative care program): Patients receive standard palliative care
from their physician/nurse practitioner team and have access to the palliative care
nurse at the discretion of the treating physician.
Patients complete Functional Assessment of Chronic Illness Therapy-Palliative Care at
baseline and every 3 months thereafter. Patients and caregivers complete surveys measuring
their perception of the quality of the patient's cancer care at baseline and at 1 month.
A caregiver or family member completes the After-Death Bereaved Family Member Interview to
evaluate the adequacy of patient care at 3 months post-patient death.
PROJECTED ACCRUAL: A total of 450 patients will be accrued for this study.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
| Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
| Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
| Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
| Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
| Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
| Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
| Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
| Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
| Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
| Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
| Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
| Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
| Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
| Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
| Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
| Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
| Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|